Correspondence 0001213900-23-023225 from G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
Date: March 27, 2023 · CIK: 0001760764 · Accession: 0001213900-23-023225
AI Filing Summary & Sentiment
File numbers found in text: 333-269496
Letter
G Medical Innovations Holdings Ltd.
5 Oppenheimer St.
Rehovot, Israel 7670105
March 27, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: G Medical Innovations Holdings Ltd. (CIK: 0001760764)
Registration Statement No. 333-269496 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
G Medical Innovations Holdings Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on March 29, 2023 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable. By separate letter, the underwriter of the issuance of the securities being registered has joined in this request for acceleration.
The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
G MEDICAL INNOVATIONS HOLDINGS LTD.
Show Raw Text
CORRESP
1
filename1.htm
G Medical Innovations Holdings Ltd.
5 Oppenheimer St.
Rehovot, Israel 7670105
March 27, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
G Medical Innovations Holdings Ltd. (CIK: 0001760764)
Registration Statement No. 333-269496 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
G Medical Innovations Holdings
Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective
on March 29, 2023 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable. By separate letter, the underwriter of the issuance
of the securities being registered has joined in this request for acceleration.
The Registrant understands
that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed
public offering of the securities specified in the Registration Statement.
The Registrant respectfully
requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212)
660-3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
G MEDICAL INNOVATIONS HOLDINGS LTD.
By:
/s/ Dr. Yacov Geva
Dr. Yacov Geva
Chief Executive Officer